Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification-Reference-Cited by-同舟云学术

Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification

Published:2022-02 Issue:2 Volume:40 Page:59.e1-59.e5
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Yu Alice,Yamany Tammer,Mojtahed Amirkasra,Hanna Nawar,Nicaise Edouard,Harisinghani Mukesh,Wu Chin-Lee,Dahl Douglas M.,Wszolek Matthew,Blute Michael L.,Feldman Adam S.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference17 articles.

1. Grading of prostatic adenocarcinoma: current state and prognostic implications;Gordetsky;Diagn Pathol,2016

2. Grade groups provide improved predictions of pathological and early oncologic outcomes compared with Gleason score risk groups;Kirmiz;J Urol,2019

3. Comparing the gleason prostate biopsy and gleason prostatectomy grading system: the lahey clinic medical center experience and an international meta-analysis;Cohen;Eur Urol,2008

4. MRI-targeted or standard biopsy for prostate-cancer diagnosis;Kasivisvanathan;N Engl J Med,2018

5. Accuracy of MRI-targeted in-bore prostate biopsy according to the gleason score with postprostatectomy histopathologic control–a targeted biopsy-only strategy with limited number of cores;Garmer;Acad Radiol,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Systematic Biopsy in the Era of Targeted Biopsy: A Review;Current Oncology;2024-09-03

2. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?;European Urology;2024-09

3. Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy;Exploration of Targeted Anti-tumor Therapy;2024-07-30

4. Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer;Asian Journal of Andrology;2024-05-03

5. The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology;World Journal of Urology;2024-04-22